These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20840873)

  • 1. Handling missing data issues in clinical trials for rheumatic diseases.
    Wong WK; Boscardin WJ; Postlethwaite AE; Furst DE
    Contemp Clin Trials; 2011 Jan; 32(1):1-9. PubMed ID: 20840873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cautionary tale: dealing with missing data in clinical trials for rheumatic diseases.
    Song J; Boscardin WJ; Furst DE; Khanna D; Wong WK
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-122-6. PubMed ID: 25372798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Move over LOCF: principled methods for handling missing data in sleep disorder trials.
    Olsen MK; Stechuchak KM; Edinger JD; Ulmer CS; Woolson RF
    Sleep Med; 2012 Feb; 13(2):123-32. PubMed ID: 22172964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced statistics: missing data in clinical research--part 1: an introduction and conceptual framework.
    Haukoos JS; Newgard CD
    Acad Emerg Med; 2007 Jul; 14(7):662-8. PubMed ID: 17538078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
    Siddiqui O
    J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missing data in confirmatory clinical trials.
    Flyer P; Hirman J
    J Biopharm Stat; 2009 Nov; 19(6):969-79. PubMed ID: 20183459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missing data in trials: do we have to keep carrying the last observation forward?
    Boers M
    Arthritis Rheum; 2008 Jan; 59(1):2-3. PubMed ID: 18163416
    [No Abstract]   [Full Text] [Related]  

  • 12. Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome.
    Hall SM; Delucchi KL; Velicer WF; Kahler CW; Ranger-Moore J; Hedeker D; Tsoh JY; Niaura R
    Nicotine Tob Res; 2001 Aug; 3(3):193-202. PubMed ID: 11506764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Handling missing data in vaccine clinical trials for immunogenicity and safety evaluation.
    Li X; Wang WW; Liu GF; Chan IS
    J Biopharm Stat; 2011 Mar; 21(2):294-310. PubMed ID: 21391003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations.
    Mallinckrodt CH; Clark SW; Carroll RJ; Molenbergh G
    J Biopharm Stat; 2003 May; 13(2):179-90. PubMed ID: 12729388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
    Yang X; Shoptaw S
    Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 17. Random effects and latent processes approaches for analyzing binary longitudinal data with missingness: a comparison of approaches using opiate clinical trial data.
    Albert PS; Follmann DA
    Stat Methods Med Res; 2007 Oct; 16(5):417-39. PubMed ID: 17656452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline observation carry forward: reasoning, properties, and practical issues.
    Shao J; Jordan DC; Pritchett YL
    J Biopharm Stat; 2009 Jul; 19(4):672-84. PubMed ID: 20183433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing incomplete longitudinal clinical trial data.
    Molenberghs G; Thijs H; Jansen I; Beunckens C; Kenward MG; Mallinckrodt C; Carroll RJ
    Biostatistics; 2004 Jul; 5(3):445-64. PubMed ID: 15208205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes.
    Wood AM; White IR; Hillsdon M; Carpenter J
    Int J Epidemiol; 2005 Feb; 34(1):89-99. PubMed ID: 15333619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.